FDA Approves MannKind's Inhaled Insulin for Children with Diabetes
The FDA approved expanded use of MannKind's inhaled rapid-acting insulin for children under 18 with diabetes, offering pediatric patients a needle-free treatment option for the first time.
·1 source
